Abstract
The excretion and biotransformation of [14C] 1,1-dichloroethylene (vinylidene chloride, VDC) after administration of a single oral dose has been investigated in female rats. Seventy-two hours after a dose of 0.5, 5.0, and 50.0 mg/kg, 1.26, 9.70, 16.47%, respectively, are exhaled as unchanged VDC, and 13.64, 11.35, 6.13% as 14CO2. The main pathway of elimination is through renal excretion with 43.55, 53.88, 42.11% of the administered radioactivity. Through the biliary system, 15.74, 14.54, 7.65% of the activity are eliminated.
The isolation of the main metabolites of VDC from 24 h urine is accomplished through the combined application of solvent extraction, ion exchange chromatography and thin layer chromatography. Then gas chromatography and mass spectrometry are used for their identification. Three metabolites have been identified: thiodiglycolic acid, N-acetyl-S-(2-carboxymethyl)cysteine and methylthio-acetylaminoethanol. In addition, three smaller unidentified radioactive peaks have been found. Thiodiglycolic acid is the main metabolite in VDC metabolism. The simultaneous formation of an ethanolamine- and a cysteine-conjugation product points to different reaction pathways of the postulated intermediate reactive epoxide; ethanolamine probably originates from membrane lipids, which react with VDC-epoxide and/or its derivatives. This pathway could explain, in part, the parenchyma damaging effect of VDC.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bartsch, H., Malaveille, C., Montesano, R., Tomatis, L.: Tissue mediated mutagenicity of vinylidene chloride and 2-chlorobutadiene in Salmonella typhimurium. Nature 255, 641–643 (1975)
Bonse, G., Urban, Th., Reichert, D., Henschler, D.: Chemical reactivity, metabolic oxirane formation and biological reactivity of chlorinated ethylenes in the isolated perfused rat liver preparation. Biochem. Pharmacol. 24, 1829–1834 (1975)
Cohen, E. N., Trudell, J. R., Edmunds, H. N., Watson, E.: Urinary metabolites of halothane in man. Anesthesiology 43, 392–401 (1975)
Creech, J. L., Johnson, M. N.: Angiosarcoma of liver in the manufacture of polyvinyl chloride. J. Occup. Med. 16, 150–151 (1974)
Greim, H., Bonse, G., Radwan, Z., Reichert, D., Henschler, D.: Mutagenicity in vitro and potential carcinogenicity of chlorinated ethylenes as a function of metabolic oxirane formation. Biochem. Pharmacol. 24, 2013–2017 (1975)
Jaeger, R. J., Conolly, R. B., Murphy, S. D.: Effect of 18 h fast and glutathione depletion on 1,1-dichloroethylene-induced hepatotoxicity and lethality in rats. Exp. Mol. Pathol. 20, 187–198 (1974)
Jenden, D. I., Booth, R. A., Rock, M.: Simultaneous microestimation of choline and acetylcholine by gas chromatography. Anal. Chem. 44, 1879–1881 (1972)
Jenner, P., Testa, B.: Novel pathways in drug metabolism. Xenobiotica 8, 1–25 (1978)
Jones, B. K., Hathway, D. E.: The biological fate of vinylidene chloride in rats. Chem.-Biol. Interact. 20, 27–41 (1978)
Kaiser, F. E., Gehrke, C. W., Zumwalt, R. W., Kuo, K. C.: Amino acid analysis. Hydrolysis, ionexchange clean-up, derivatization, and quantitation by gas-liquid chromatography. J. Chromatogr. 94, 113–133 (1974)
Knight, H. R., Young, L.: Biochemical studies of toxic agents. Biochem. J. 70, 111–119 (1958)
Lee, F. J., Harry, D. S.: Angiosarcoma of the liver in an vinyl chloride worker. Lancet I, 1316–1318 (1974)
Maltoni, C., Lefemine, G.: Carcinogenicity bioassays of vinyl chloride. Research plan and early results. Ann. N.Y. Acad. Sci. 246, 195–218 (1975)
McKenna, M. I., Zempel, J. A., Madrid, E. O., Braun, W. H.: Metabolism and pharmacokinetic profile of vinylidene chloride in rats following oral administration. Toxicol. Appl. Pharmacol. 45, 821–835 (1978)
Ozawa, H.: The dehydrating cyclization of S-carboxymethyl-cysteine and N-acetyl-S-carboxymethyl-cysteine. Bull. Chem. Soc. Japan 36, 920–922 (1963)
Reichert, D., Bashti, N.: Metabolism and disposition of 1.1-dichloroethylene in the isolated blood-perfused liver of the rat. Naunyn-Schmiedeberg's Arch. Pharmacol. [Suppl.] 293, R255 (1976)
Reichert, D., Henschler, D.: Uptake and hepatotoxicity of 1.1-dichloroethylene by the isolated blood-perfused rat liver. Int. Arch. Occup. Environ. Health 41, 169–178 (1978)
Reichert, D., Werner, H. W., Henschler, D.: Role of liver glutathione in 1.1-dichloroethylene metabolism and hepatotoxicity in intact rats and isolated perfused rat liver. Arch. Toxicol. 41, 169–178 (1978)
Reichert, D., Werner, H. W.: Disposition and metabolism of [14C] 1.1-dichloroethylene after single oral administration in rats. Naunyn-Schmiedeberg's Arch. Pharmacol. [Suppl.] 302, R22 (1978)
Viola, P. L., Caputo, A.: Carcinogenicity studies on vinylidene chloride. Environ. Health Perspect. 21, 45–47 (1977)
Watanabe, P. C., McGowan, G. R., Madrid, E. O., Gehring, P. J.: Fate of [14C] vinyl chloride following inhalation exposure in rats. Toxicol. Appl. Pharmacol. 37, 49–59 (1976)
Yllner, S.: Metabolism of chloroacetate-1-14C in the mouse. Acta Pharmacol. (Kbh.) 30, 69–80 (1970)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Reichert, D., Werner, H.W., Metzler, M. et al. Molecular mechanism of 1,1-dichloroethylene toxicity: excreted metabolites reveal different pathways of reactive intermediates. Arch. Toxicol. 42, 159–169 (1978). https://doi.org/10.1007/BF00353707
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00353707